New cancer drug daraxonrasib doubles survival time in advanced pancreatic cancer trials.
Browsing: breakthrough
Stanford scientists restored lost knee cartilage and reversed arthritis in aging mice by blocking a protein tied to the aging process, raising hopes for human clinical trials.